explore -WSS

explore

author：comprehensive 2025-09-30 00:48:25 - browse：98487

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medicare Advantage today, explained in one chart

knowledge

WSS

OTC birth control: A brief history of over the counter pill design

Humana, CVS hope to turn members into patients at clinics

NIH director takes cautious approach to Biden drug pricing priority

Verily hires former Apple Health leader as chief scientific officer

Biotech venture capitalists face new demands from investors

Research misconduct: Proposed new rules face resistance

Wikipedia

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

Nearly two

How to save PrEP access — and even expand it

TytoCare raises $49 million to build out AI

How to save PrEP access — and even expand it

For BCIs, commercial hurdles may be bigger than scientific ones

Supreme Court strikes down use of affirmative action

Attacks on the drug industry will lead to fewer breakthroughs

United colonoscopy coverage change 'may cost lives,' doctors say

Copay coupons to count toward deductibles, after Biden court move

knowledge

'Ancient DNA,' 23andMe reveal African American ancestries

My yearlong odyssey to get my son’s ADHD medication covered

What Henrietta Lacks settlement says about racism in medicine

Biden calls for immediate release of Niger's president amid apparent coup

The tragedy of Johnson & Johnson’s Covid vaccine

Francis Collins on trust in science and how Covid communications failed

Wikipedia

knowledge

knowledge

knowledge